| 5-FU | 5-fluorouracil |
| 4E-BP1 | eIF4E binding protein-1 |
| AKT ara-c ASK1 |
Protein kinase B Cytosine arabinoside Apoptosis signal-regulating kinase 1 |
| ATM | Ataxia-telangiectasia mutated |
| CFZ | Carfilzomib |
| CPT-11 | Irinotecan/Camptothecin-11 |
| eIF4E | Eukaryotic translation initiation factor 4E |
| ERK1/2 | Extracellular signal-regulated-1/2-ER2 |
| FOLFOX | Folinic acid, 5-fluorouracil, Oxaliplatin |
| HIF-1α | Hypoxia-inducible factor 1-alpha |
| HuR | Hu antigen R |
| MAPKK/MKK | Mitogen-activated protein kinase kinase |
| MEKK3 | Mitogen-activated protein kinase kinase kinase 3 |
| MKP-1 | Mitogen-activated protein kinase 1 |
| MKNK1 | MAPK-interacting kinase 1 |
| OM | Oxymatrine |
| mTOR | Mammalian phosphorylation target of rapamycin |
| p70S6K | Ribosomal protein S6 kinase |
| PAI-1 | Plasminogen activator inhibitor 1 |
| PCNA | Proliferating Cell Nuclear Antigen |
| PFS | Progression-free survival |
| PP2AC | Serine/threonine-protein phosphatase 2A catalytic subunit alpha isoform |
| PXR | Pregnane X receptor |
| RT | Radiotherapy |
| SAPK/JNK | c-Jun N-terminal kinases |
| SN-38 | 7-etil-10-idrossi-camptotecina |
| SMAD | Small mother against decapentaplegic |
| TGFβ-1 | Transforming growth factor beta 1 |
| TP53 | Tumor protein p53 |
| TPL2 | Tumor progression locus 2 |